Enveric Biosciences Inc (ENVB) — Cash Flow-to-Debt Ratio
Enveric Biosciences Inc (ENVB) has a Cash Flow-to-Debt Ratio of -2.29x as of September 2025, meaning its operating cash flow of $-2.07 Million could theoretically repay -2% of its total liabilities ($905.88K) in one year. See ENVB financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Enveric Biosciences Inc Cash Flow-to-Debt Ratio (1994–2024)
Historical debt coverage capacity for Enveric Biosciences Inc across 31 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Enveric Biosciences Inc.
Annual Cash Flow-to-Debt Ratio for Enveric Biosciences Inc (1994–2024)
Year-by-year debt coverage analysis for Enveric Biosciences Inc. Check Enveric Biosciences Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -5.19x | $-7.73 Million | $1.49 Million | ▲ +13.8% |
| 2023 | -6.01x | $-14.09 Million | $2.34 Million | ▼ -40.2% |
| 2022 | -4.29x | $-17.15 Million | $4.00 Million | ▼ -65.3% |
| 2021 | -2.60x | $-11.46 Million | $4.41 Million | ▲ +54.5% |
| 2020 | -5.71x | $-3.89 Million | $681.25K | ▼ -12573.4% |
| 2019 | -0.05x | $-647.86K | $14.38 Million | ▲ +66.9% |
| 2018 | -0.14x | $-2.57 Million | $18.88 Million | ▼ -62.4% |
| 2017 | -0.08x | $-2.74 Million | $32.75 Million | ▲ +13.8% |
| 2016 | -0.10x | $-2.70 Million | $27.84 Million | ▲ +64.1% |
| 2015 | -0.27x | $-3.67 Million | $13.58 Million | ▲ +94.4% |
| 2014 | -4.82x | $-43.16K | $8.96K | ▼ -450.2% |
| 2013 | -0.88x | $-21.63K | $24.70K | ▲ +9.5% |
| 2012 | -0.97x | $-24.85K | $25.67K | ▲ +42.9% |
| 2011 | -1.70x | $-30.35K | $17.89K | ▼ -111.2% |
| 2010 | -0.80x | $-40.67K | $50.64K | ▲ +85.3% |
| 2009 | -5.48x | $-65.04K | $11.87K | ▲ +22.6% |
| 2008 | -7.08x | $-150.19K | $21.21K | ▼ -202.8% |
| 2007 | 6.89x | $329.93K | $47.90K | ▲ +296.0% |
| 2006 | -3.51x | $-305.91K | $87.08K | ▼ -145.8% |
| 2005 | -1.43x | $-256.57K | $179.52K | ▼ -376.9% |
| 2004 | 0.52x | $343.94K | $666.31K | ▲ +150.8% |
| 2003 | -1.02x | $-253.97K | $249.77K | ▼ -478.6% |
| 2002 | 0.27x | $85.14K | $317.01K | ▲ +127.0% |
| 2001 | -0.99x | $-339.68K | $341.54K | ▼ -649.9% |
| 2000 | 0.18x | $145.84K | $806.35K | ▲ +136.7% |
| 1999 | -0.49x | $-665.38K | $1.35 Million | ▲ +59.8% |
| 1998 | -1.22x | $-3.00 Million | $2.45 Million | ▲ +45.7% |
| 1997 | -2.25x | $-3.70 Million | $1.64 Million | ▲ +58.3% |
| 1996 | -5.41x | $-4.72 Million | $873.32K | ▼ -5.2% |
| 1995 | -5.14x | $-3.60 Million | $700.00K | ▼ -478.6% |
| 1994 | -0.89x | $-800.00K | $900.00K | — |